Literature DB >> 12746338

Neuronal histamine regulates food intake, adiposity, and uncoupling protein expression in agouti yellow (A(y)/a) obese mice.

Takayuki Masaki1, Seiichi Chiba, Go Yoshimichi, Tohru Yasuda, Hitoshi Noguchi, Tetsuya Kakuma, Toshiie Sakata, Hironobu Yoshimatsu.   

Abstract

Hypothalamic neuronal histamine and its H(1) receptor (H(1)-R) form a part of the leptin-signaling pathway in the brain and have been shown to regulate body weight and adiposity in diabetic (db/db) and diet-induced obese mice by affecting food intake and uncoupling protein mRNA expression. The proopiomelanocortin (POMC) melanocortin-4 receptor (MC-4R) is also important for leptin signaling. The present study had two aims: first, to clarify the antiobesity action of neuronal histamine in agouti yellow (A(y)/a) obese mice, a model of obesity in which POMC/MC-4R signaling is disrupted by blockade of MC-4R and second, to investigate the functional relationship between neuronal histamine and POMC/MC-4R signaling. Central administration of histamine into the lateral cerebroventricle decreased cumulative food intake and body weight in A(y)/a obese mice. Histamine treatment also decreased mRNA expression of ob gene in epididymal white adipose tissue and up-regulated uncoupling protein 1 mRNA expression in brown adipose tissue. These effects were attenuated in A(y)/a obese mice with histamine H(1)-receptor (H(1)-R) knockout. Histamine treatment induced c-Fos-like immunoreactivity in both paraventricular and arcuate nucleus. There was no significant difference in histamine-induced c-Fos-like immunoreactivity in the hypothalamus between A(y)/a obese mice and lean littermates, indicating histamine signaling was not disrupted at the hypothalamic level in A(y)/a obese mice. These results suggest that neuronal histamine have an antiobese action, even in A(y)/a obese mice despite a deficiency in POMC/MC-4R signaling. In addition, it appears that the histamine H(1)-R signaling pathway may be independent or downstream of the POMC/MC-4R signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746338     DOI: 10.1210/en.2003-0031

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Dipsogenic potentiation by sodium chloride but not by sucrose or polyethylene glycol in tuberomammillary-mediated polydipsia.

Authors:  J Mahía; A Bernal; A Puerto
Journal:  Exp Brain Res       Date:  2007-07-14       Impact factor: 1.972

2.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 3.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 4.  Histamine receptor signaling in energy homeostasis.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2015-06-21       Impact factor: 5.250

5.  Increased E4 activity in mice leads to ubiquitin-containing aggregates and degeneration of hypothalamic neurons resulting in obesity.

Authors:  Etsuo Susaki; Chie Kaneko-Oshikawa; Keishi Miyata; Mitsuhisa Tabata; Tetsuya Yamada; Yuichi Oike; Hideki Katagiri; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

6.  CX3CL1 Action on Microglia Protects from Diet-Induced Obesity by Restoring POMC Neuronal Excitability and Melanocortin System Activity Impaired by High-Fat Diet Feeding.

Authors:  Jineta Banerjee; Mauricio D Dorfman; Rachael Fasnacht; John D Douglass; Alice C Wyse-Jackson; Andres Barria; Joshua P Thaler
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

7.  Quantitative trait loci that control body weight in DDD/Sgn and C57BL/6J inbred mice.

Authors:  Jun-Ichi Suto; Misaki Kojima
Journal:  Mamm Genome       Date:  2016-10-17       Impact factor: 2.957

Review 8.  Obesity pharmacotherapy: what is next?

Authors:  Francheska Colon-Gonzalez; Gilbert W Kim; Jieru E Lin; Michael A Valentino; Scott A Waldman
Journal:  Mol Aspects Med       Date:  2012-10-24

Review 9.  The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.

Authors:  Meng He; Chao Deng; Xu-Feng Huang
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

10.  Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells.

Authors:  Ji-Ah Kang; Keimin Lee; Kwang Min Lee; Sukhee Cho; Jinsoo Seo; Eun-Mi Hur; Chul-Seung Park; Ja-Hyun Baik; Se-Young Choi
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.